Logo image of MAXN

MAXEON SOLAR TECHNOLOGIE (MAXN) Stock Fundamental Analysis

NASDAQ:MAXN - SGXZ57724486 - Common Stock

3.52 USD
-0.13 (-3.56%)
Last: 9/2/2025, 3:00:55 PM
Fundamental Rating

1

Overall MAXN gets a fundamental rating of 1 out of 10. We evaluated MAXN against 112 industry peers in the Semiconductors & Semiconductor Equipment industry. MAXN has a bad profitability rating. Also its financial health evaluation is rather negative. MAXN is quite expensive at the moment. It does show a decent growth rate.


Dividend Valuation Growth Profitability Health

Quickly go to:

0

1. Profitability

1.1 Basic Checks

In the past year MAXN has reported negative net income.
In the past year MAXN has reported a negative cash flow from operations.
In the past 5 years MAXN always reported negative net income.
In the past 5 years MAXN reported 4 times negative operating cash flow.
MAXN Yearly Net Income VS EBIT VS OCF VS FCFMAXN Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2018 2019 2020 2021 2022 2023 2024 0 -200M -400M -600M

1.2 Ratios

The Return On Assets of MAXN (-329.72%) is worse than 98.21% of its industry peers.
Industry RankSector Rank
ROA -329.72%
ROE N/A
ROIC N/A
ROA(3y)-70.67%
ROA(5y)-50.13%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
MAXN Yearly ROA, ROE, ROICMAXN Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2018 2019 2020 2021 2022 2023 2024 0 5K 10K 15K 20K

1.3 Margins

The Profit Margin and Operating Margin and Gross Margin are not available for MAXN so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM N/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
MAXN Yearly Profit, Operating, Gross MarginsMAXN Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2018 2019 2020 2021 2022 2023 2024 0 -20 -40 -60 -80 -100

More info and screens

0

2. Health

2.1 Basic Checks

MAXN does not have a ROIC to compare to the WACC, probably because it is not profitable.
MAXN has more shares outstanding than it did 1 year ago.
The number of shares outstanding for MAXN has been reduced compared to 5 years ago.
Compared to 1 year ago, MAXN has a worse debt to assets ratio.
MAXN Yearly Shares OutstandingMAXN Yearly Shares OutstandingYearly Shares Outstanding 2018 2019 2020 2021 2022 2023 2024 10M 20M 30M 40M
MAXN Yearly Total Debt VS Total AssetsMAXN Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2018 2019 2020 2021 2022 2023 2024 200M 400M 600M 800M 1B

2.2 Solvency

Based on the Altman-Z score of -16.50, we must say that MAXN is in the distress zone and has some risk of bankruptcy.
MAXN has a worse Altman-Z score (-16.50) than 83.04% of its industry peers.
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF N/A
Altman-Z -16.5
ROIC/WACCN/A
WACC5.87%
MAXN Yearly LT Debt VS Equity VS FCFMAXN Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2018 2019 2020 2021 2022 2023 2024 0 200M -200M 400M

2.3 Liquidity

A Current Ratio of 0.84 indicates that MAXN may have some problems paying its short term obligations.
With a Current ratio value of 0.84, MAXN is not doing good in the industry: 94.64% of the companies in the same industry are doing better.
MAXN has a Quick Ratio of 0.84. This is a bad value and indicates that MAXN is not financially healthy enough and could expect problems in meeting its short term obligations.
With a Quick ratio value of 0.64, MAXN is not doing good in the industry: 93.75% of the companies in the same industry are doing better.
Industry RankSector Rank
Current Ratio 0.84
Quick Ratio 0.64
MAXN Yearly Current Assets VS Current LiabilitesMAXN Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2018 2019 2020 2021 2022 2023 2024 200M 400M 600M

More info and screens

4

3. Growth

3.1 Past

The Earnings Per Share has grown by an impressive 83.86% over the past year.
MAXN shows a very negative growth in Revenue. In the last year, the Revenue has decreased by -54.68%.
Measured over the past years, MAXN shows a very negative growth in Revenue. The Revenue has been decreasing by -15.74% on average per year.
EPS 1Y (TTM)83.86%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%80.53%
Revenue 1Y (TTM)-54.68%
Revenue growth 3Y-13.38%
Revenue growth 5Y-15.74%
Sales Q2Q%-78.81%

3.2 Future

MAXN is expected to show a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 41.42% yearly.
The Revenue is expected to grow by 38.94% on average over the next years. This is a very strong growth
EPS Next Y99.98%
EPS Next 2Y41.42%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next Year54.92%
Revenue Next 2Y38.94%
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

The Revenue growth rate is accelerating: in the next years the growth will be better than in the last years.
MAXN Yearly Revenue VS EstimatesMAXN Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2018 2019 2020 2021 2022 2023 2024 2025 2026 200M 400M 600M 800M 1B
MAXN Yearly EPS VS EstimatesMAXN Yearly EPS VS EstimatesYearly EPS VS Estimates 2020 2021 2022 2023 2024 2025 2026 -200 -400 -600

More info and screens

1

4. Valuation

4.1 Price/Earnings Ratio

MAXN reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
Also next year MAXN is expected to report negative earnings again, which makes the also the Forward Price/Earnings Ratio negative.
Industry RankSector Rank
PE N/A
Fwd PE N/A
MAXN Price Earnings VS Forward Price EarningsMAXN Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 50 -50 -100 -150

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
MAXN Per share dataMAXN EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 -100 -200

4.3 Compensation for Growth

A more expensive valuation may be justified as MAXN's earnings are expected to grow with 41.42% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y41.42%
EPS Next 3YN/A

More info and screens

0

5. Dividend

5.1 Amount

MAXN does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

MAXEON SOLAR TECHNOLOGIE

NASDAQ:MAXN (9/2/2025, 3:00:55 PM)

3.52

-0.13 (-3.56%)

Chartmill FA Rating
GICS SectorInformation Technology
GICS IndustryGroupSemiconductors & Semiconductor Equipment
GICS IndustrySemiconductors & Semiconductor Equipment
Earnings (Last)04-30 2025-04-30/amc
Earnings (Next)12-03 2025-12-03/amc
Inst Owners4.62%
Inst Owner Change0%
Ins Owners0.5%
Ins Owner ChangeN/A
Market Cap59.59M
Analysts43.33
Price Target2.14 (-39.2%)
Short Float %14.54%
Short Ratio5.31
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)0
Avg Revenue beat(2)-80.82%
Min Revenue beat(2)-84%
Max Revenue beat(2)-77.64%
Revenue beat(4)0
Avg Revenue beat(4)-64.29%
Min Revenue beat(4)-84%
Max Revenue beat(4)-15.54%
Revenue beat(8)1
Avg Revenue beat(8)-33.37%
Revenue beat(12)2
Avg Revenue beat(12)-23.52%
Revenue beat(16)4
Avg Revenue beat(16)-17.62%
PT rev (1m)0%
PT rev (3m)-96.26%
EPS NQ rev (1m)0%
EPS NQ rev (3m)0%
EPS NY rev (1m)0%
EPS NY rev (3m)0%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)0%
Revenue NY rev (1m)0%
Revenue NY rev (3m)0%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 0.12
P/FCF N/A
P/OCF N/A
P/B N/A
P/tB N/A
EV/EBITDA N/A
EPS(TTM)-294.03
EYN/A
EPS(NY)-0.02
Fwd EYN/A
FCF(TTM)-13.87
FCFYN/A
OCF(TTM)-12.89
OCFYN/A
SpS30.07
BVpS-19.34
TBVpS-19.37
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -329.72%
ROE N/A
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM N/A
FCFM N/A
ROA(3y)-70.67%
ROA(5y)-50.13%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score2
Asset Turnover2.73
Health
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 66.47%
Cap/Sales 3.24%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 0.84
Quick Ratio 0.64
Altman-Z -16.5
F-Score2
WACC5.87%
ROIC/WACCN/A
Cap/Depr(3y)117.96%
Cap/Depr(5y)155.57%
Cap/Sales(3y)7.42%
Cap/Sales(5y)9.04%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)83.86%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%80.53%
EPS Next Y99.98%
EPS Next 2Y41.42%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)-54.68%
Revenue growth 3Y-13.38%
Revenue growth 5Y-15.74%
Sales Q2Q%-78.81%
Revenue Next Year54.92%
Revenue Next 2Y38.94%
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y-555.71%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year94.46%
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y-158.13%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-721.41%
OCF growth 3YN/A
OCF growth 5YN/A